GenSight Biologics Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, GenSight Biologics stock has a consensus rating of "Buy" and an average price target of €0.31. The average 1-year stock price forecast is 289.94% higher than the current stock price, while the lowest is €0.21 (+164.15%) and the highest is €0.40 (+403.14%).

Price Target: €0.31 (+289.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	€0.21	€0.31	€0.31	€0.40
Change	+164.15%	+289.94%	+289.94%	+403.14%

* Price targets were last updated on Apr 8, 2026.

Analyst Ratings

The average analyst rating for GenSight Biologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Jan '26	Mar '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Justine Telliez Kepler Capital	Kepler Capital	Hold Maintains €0.40	Hold	Maintains	€0.40	+403.14%	Apr 8, 2026

Financial Forecast

Revenue This Year

5.50M

from 652.00K

743.56%

from 652.00K

Revenue Next Year

41.60M

from 5.50M

656.36%

from 5.50M

EPS This Year

-0.83

from -0.08

EPS Next Year

-0.53

from -0.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	7.71M	4.87M	2.96M	2.63M	652.00K	5.50M
Revenue Growth	3.62%	-36.89%	-39.08%	-11.44%	-75.16%	743.56%
Gross Profit	7.71M	4.87M	2.96M	2.63M	652.00K	4.79M
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	87.00%
Operating Income	-28.13M	-27.84M	-29.70M	-15.81M	-11.05M	-31.91M
Net Income	-28.62M	-27.63M	-26.22M	-14.00M	-12.04M	-65.34M
EPS	-	-	-	-	-0.08	-0.83
Free Cash Flow	-13.79M	-29.49M	-14.13M	-6.69M	-7.24M	-14.20M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	5.5M
Avg	5.5M
Low	5.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	743.6%
Avg	743.6%
Low	743.6%

EPS Forecast

EPS	2026	2027	2028
High	-0.83
Avg	-0.83
Low	-0.83

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-